Arkolith/Insider Trading/MLYS/Form 4

Rodman David Malcom

Chief Medical OfficerMineralys Therapeutics, Inc. (MLYS) · full profile →Form 4 · filed Jun 12, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$206K
Net Open-Market Flow
-$206K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 12, 2026Option exercise(M)6K$1.08$7K70K
Jun 12, 2026Sell(S)6K$23.93$152K63K
Jun 10, 2026Option exercise(M)2K$16.00$35K66K
Jun 10, 2026Sell(S)2K$25.00$54K63K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 12, 2026Option exercise(M)6K—$06K
Jun 10, 2026Option exercise(M)2K—$017K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001672659-26-000030) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML